Reads pretty good to me. I like the highlighted highlights below.
HIGHLIGHTS
• Preliminary Economic Assessment (PEA) completed by independent consultants, BBA and Primero, outlining a preliminary base case scenario for a staged development of the cornerstone CV5 Spodumene Pegmatite, via both open pit and underground mining methods.
• High-grade Nova Zone1 (including 21.8 million tonnes at 2.1% Li2O of which 93% is Indicated, 7% is Inferred Resource category respectively) to be targeted and prioritised via underground mining methods, allowing direct access to higher grade material and minimizing the environmental footprint.
• At the targeted Stage 2 production rate of ~800 ktpa2 spodumene concentrate, this would potentially position Patriot as the 4th largest spodumene concentrate producer globally3.
• Potential pre-tax net present value (“NPV”8% of $4.7 billion (US$3.6 billion) and after-tax NPV8% of $2.9 billion (US$2.2 billion) with a pre-tax internal rate of return (“IRR”
of 38% (after-tax IRR of 34%) at US$1,375 per tonne (SC5.5, FOB Bécancour basis).
• Payback period of 3.6 years at an assumed average lithium price of US$1,375 per tonne (SC5.5, FOB Bécancour basis) or US$1,500 per tonne (SC6, FOB Bécancour basis), with life of mine (“LOM”of up to 24 years.
• Targeting to become a North American top-tier, lower cost producer with an estimated average LOM cash operating cost4 at site of $510 per tonne (US$387) and total cash operating costfree-on-board (“FOB” Bécancour)1 of $736 per tonne (US$560)2.
• An estimated break-even SC6 price (on a fully ramped 800 ktpa, EBITDA, FOB Bécancour basis) of US$587/t highlights the potentially viable nature of the Shaakichiuwaanaan Project throughout the lithium price cycle.
• Estimated to indicatively generate approximately $8.3 billion in Project Cash Flow (unlevered) over LOM.
• Average annual EBITDA3 anticipated to be in the order of $850M and annual FCF4 of $515M at an assumed spodumene price of US$1,375 per tonne (SC5.5, FOB Bécancour basis).
• Phased development strategy with anticipated Stage 1 capital expenditure estimate of $761M (US$579M) for the first 400 ktpa capacity including contingency and Net Capex of $640M (US$487M) leveraging the proposed 30% Canadian Clean Technology Manufacturing – Investment Tax Credit (“CTM-ITC”5. • Estimated Stage 2 expansion Capex of $504M (US$383M) including contingency and Net Capex of $408M (US$310M) leveraging the proposed CTM-ITC, to reach a production capacity of ~800 ktpa of spodumene concentrate per year.
• The combined net cost6 to reach nameplate production for both Stage 1 and Stage 2 is estimated to be approximately $608M (US$462M) taking into account funding that could come from both cash flows from Stage 1 and proposed CMT-ITC tax credits.
• Process plant feed rate following Stage 2 expansion at an average of ~4.5 Mtpa7 via simple DMS only process; average LOM lithia recovery of 69.5%; spodumene concentrate grade at 5.5% Li2O.
• Access to existing, high quality transportation infrastructure with potential future improvements in the region combined with a low-carbon footprint, low cost and mainly renewable electricity source.
• Tier 1, stable mining jurisdiction of Eeyou Istchee James Bay region of Québec (under modern land claims agreement – James Bay Northern Quebec Agreement “JBNQA”combined with a strong relationship with the Cree Nation of Chisasibi, Cree Nation Government and all stakeholders.
- Forums
- ASX - By Stock
- Ann: Preliminary Economic Assessment on Shaakichiuwaanaan Project
PMT
patriot battery metals inc.
Add to My Watchlist
10.6%
!
26.0¢

Reads pretty good to me. I like the highlighted highlights...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.025(10.6%) |
Mkt cap ! $140.2M |
Open | High | Low | Value | Volume |
24.5¢ | 26.5¢ | 24.5¢ | $1.061M | 4.137M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 55273 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 18971 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2588 | 0.280 |
1 | 1088 | 0.265 |
1 | 2413 | 0.260 |
1 | 5000 | 0.255 |
3 | 55000 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 10350 | 4 |
0.235 | 38019 | 3 |
0.245 | 614208 | 3 |
0.260 | 4562 | 5 |
0.270 | 127021 | 7 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
PMT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online